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Background and purpose: Sex related differences in cardiovascular disease and stroke are issues of increasing
interest. The aim of this study was to evaluate for sex differences in clinical presentation, severity of stroke
and outcome in a population of patients admitted to 4 public and 1 private hospitals in three different regions
of Italy.
Methods: All hospital admissions for ischemic and haemorrhagic stroke (ICD-IX code 434 and 431 respectively)
between January 1st andDecember 31st, 2011 atﬁve different hospitals located in three different regions of Italy:
Milan (North), Rome and Perugia (Center), and Palermo (South) have been recorded and sex-differences have
been evaluated.
Results: A total of 1272 stroke patients were included in the analysis: 1152 ischemic and 120 haemorrhagic
strokes, 567 women and 705 men. Compared to men, women were signiﬁcantly older (mean age 75.2 SD
13.7 vs 71.5 SD 12.5 years, Pb0.001) and their stroke severities at onset, measured by NIHSS, were also
compared to men (10 SD 8 vs 8 SD 7, Pb0.001).
Female sex was associated with a worse functional prognosis measured by modiﬁed Rankin Scale score
(mRS≥3), as well as in-hospital mortality, without reaching statistical signiﬁcance.
There were no observed signiﬁcant differences between sexes regarding the number of patients treated with
thrombolytic therapy. Analysis of the distribution of risk factors between sexes showed a prevalence of atrial
ﬁbrillation in women (29% vs 21%, P=0.003).
Conclusions: Both stroke severity and functional outcome were worse in women.© 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.1. Introduction
Stroke in women is a recognized public health issue worldwide
because of its inﬂuence on post-stroke disability [1]. Since women
have longer life expectancies, there is a higher stroke prevalence in
women [2,3], and this sex difference in the number of stroke events
is expected to increase further over the next few decades [4,5]. More-




ation of Internal Medicine. Publishe[6,7], and a higher mortality especially in the oldest age groups [8]. In
fact, at onset, women tend to be 4 to 5 years older, on average, than
men and present more comorbidities [9,10], both these variables
affect the severity of stroke at presentation and impact the timelines
of acute stroke care.
The aim of this study was to evaluate for sex-differences in clinical
presentation, severity of stroke and outcome in patients admitted to
ﬁve hospitals in three different regions of Italy.
2. Subjects and methods
Consecutive stroke patients admitted to ﬁve Italian hospitals, 4
public (Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,
Milan; Santa Maria della Misericordia Hospital, Perugia; San Camillo
Forlanini Hospital, Rome; and Civico Hospital, Palermo) and 1 privated by Elsevier B.V. All rights reserved.
Table 1
Age, hospital stay and NIHSS at onset and discharge by sex in the whole population.
Sex N Mean SD P value
Age Female 566 75.2 13.7 b0.001
Male 703 71.5 12.5
Hospital stay Female 396 10.8 7.8 0.001
Male 520 9.5 7.5
NIHSS at onset Female 550 9.9 7.8 b0.001
Male 689 7.9 7.0
NIHSS at discharge Female 357 6.7 7.5 0.002
Male 462 4.9 6.2
Table 2
Thrombolytic treatment, in-hospital death and functional outcome by sex.
F M Total P value
Thrombolytic treatment No n 369 465 834 0.392
% 90.0 88.2 89.0
Yes n 41 62 103
% 10.0 11.8 11.0
Total n 410 527 937
% 100 100 100
In-hospital death No n 425 560 985 0.499
% 94.7 95.6 95.2
Yes n 24 26 50
% 5.3 4.4 4.8
Total n 449 586 1035
% 100 100 100
mRS score at discharge b=2 n 252 368 620 0.030
% 56.1 62.8 59.9
3+ n 197 218 415
% 43.9 37.2 40.1
Total n 449 586 1035
% 100 100 100
3 months-mRS b=2 n 89 146 235 0.022
% 48.9 60.1 55.3
3+ n 93 97 190
% 51.1 39.9 44.7
Total n 182 243 425
% 100 100 100
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Italy, discharged with the codes for ischemic and haemorrhagic stroke
according to the International Classiﬁcation of Diseases (ICD-IX codes
434 and 431 respectively) between January 1st and December 31st
2011, were recorded in the Stroke Units databases.
Each database was analyzed for data on sex differences regarding
stroke severity at clinical presentation assessed by National Institute of
Health Stroke Scale (NIHSS) [11], functional outcome assessed by
modiﬁed Rankin Scale score (mRS) [12] at discharge and in-hospital
mortality were recorded.
Each hospital followed Human Research rules and this observa-
tional study was approved by the local hospital boards.
All patients were managed in sub-intensive stroke units and stan-
dard stroke care guidelines [13,14] were followed.
Patients admitted within 3 h from stroke onset meeting SITS-MOST
criteria and according to physicians discretion were treated with
thrombolysis [15]. Information concerning inclusion/exclusion criteria
for thrombolysis were not collected.
Stroke was classiﬁed as large-artery atherosclerotic, cardioembolic,
lacunar or cryptogenic according to the Trial of Org 10172 in Acute
Stroke Treatment (TOAST) criteria [16].
Variables included in study analysis were: (1) baseline demo-
graphic characteristics (age and sex); (2) risk factors for stroke (3)
clinical stroke severity at admission and at discharge assessed by
NIHSS; (4) functional outcome, at discharge and at 3-months
follow-up, measured by mRS score; and (5) any difference in throm-
bolytic treatment and prognosis at the 5 participating hospitals.
Functional outcome was measured according to the mRS: 0, 1, 2=
no- to slight disability; 3,4, 5=moderate- to severe disability; 6=
death. For the purpose of this study, clinical outcomes (mortality
and disability) were assessed at three months, the functional out-
comes were assessed by outpatient visits or by structured telephone
interviews using mRS. Time of occurrence and cause of death were
also recorded. The causes of death were divided into: neurological
(stroke recurrence, status epilepticus, edema or herniation), cardio-
vascular (myocardial infarction, heart failure, sudden death or other
cardiovascular diseases and pulmonary embolus), and other causes
(pneumonia, cancer, and other causes).
3. Statistical analysis
Pearson's chi-square or Fisher's Exact Test were used to compare
categorized proportions.
A comparison of discrete variables was conducted using a non-
parametric test (Mann–Whitney).
Multivariate logistic regression was performed in order to deﬁne
risk factors for dichotomic outcomes.
Multivariate linear regression was carried out with the aim of
evaluating independent variables for NIHSS values at entry. An
alpha level of 0.05 was used for each statistical test.
No imputation was done for missing data.
4. Results
Over the 12-month study period, 1272 consecutive patients with
acute stroke were included in the databases of the 5 participating
hospitals: 567 patients were women (45%) and 705 men (55%);
1152 ischemic (521 women vs 631 men) and 120 haemorrhagic
strokes (46 women vs 74 men), not statistically signiﬁcant differ-
ences were observed between sexes.
Women were signiﬁcantly older than men, (mean age 75.2 SD
13.7 vs 71.5 SD 12.5 years, Pb0.001); date of birth was available for
all patients except for 1 woman and 2 men. The length of hospital
stay was longer for women (11 SD 8 vs 10 SD 8 days, p=0.001),
(Table 1).Stroke severity at admission assessed by NIHSS score was signiﬁ-
cantly worse in women than men (NIHSS 10, SD 8; median 7,
interquartile range 13 vs NIHSS 8, SD 7; 5 , interquartile range 9,
Pb0.001). Similarly, women resulted signiﬁcantlymore severely neuro-
logically impaired at discharge than men (NIHSS score 7, SD 8; median
3, interquartile range 10 vs NIHSS 5, SD 6; 2 interquartile range 5 P=
0.002), (Table 1) and multivariate linear regression revealed that
female sex and age were signiﬁcantly associated with greater stroke
severity at hospital's admission, (Table 3a).
There was no observed signiﬁcant difference between sexes in
terms of receiving thrombolysis treatment even if there was a slight
tendency for men to be treated more frequently (10% vs 12%),
(Table 2).
The in-hospital mortality was similar for both sexes (women 5% vs
male 4%) (Table 2), and the multivariate logistic model suggested that
that the following were independent predictors of in-hospital death:
age, stroke severity at onset, and length of hospital stay (Table 3b).
Regarding functional outcome assessed by mRS score, either at
discharge (44% vs 37% P=0.030) or at 90-day follow-up (51% vs
40%, P=0.022), both resulted worse (mRS≥3) for women compared
to men (Table 2); 3-months follow-up data were not available for all
patients.
Table 4 lists the distributions of risk factors for both sexes: women
were less likely to be smokers and alcohol consumers; whereas, histo-
ry of hypertension, diabetes and dyslipidemia had similar distribu-
tions between the sexes. Obesity [17] was more frequent in women
without reaching statistical signiﬁcance, while atrial ﬁbrillation (AF)
was statistically signiﬁcant in women compared to men (29% vs
21%, P=0.003).
Table 3a
Multivariate linear regression analysis for NIHSS at hospital admission.
beta P value
Sex F vs M 1.71 b0.001
Age 0.09 b0.001
Table 4
Risk factor distribution by sex.
F M Total P value
Hx of hypertension No n 110 157 267 0.319
% 26.8 29.8 28.5
Yes n 300 370 670
% 73.2 70.2 71.5
Total n 410 527 937
% 100.0 100.0 100.0
Diabetes No n 286 373 659 0.545
% 79.4 77.7 78.5
Yes n 74 107 181
% 20.6 22.3 21.5
Total n 360 480 840
% 100.0 100.0 100.0
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compared to the Center and North 9%, 11% and 13%, respectively. A
greater proportion of patients in the South were discharged with a
worse functional outcome compared to those in the Center and North
54%, 43%, and 33% respectively, Pb0.001. In-hospital mortalities were
similar among the three regions (Table 5).Smoking habit No n 395 455 850 0.001
% 83.9 75.8 79.4
Yes n 76 145 221
% 16.1 24.2 20.6
Total n 471 600 1071
% 100.0 100.0 100.0
Alchool consumption No n 296 395 691 0.010
% 99.7 97.1 98.2
Yes n 1 12 13
% 0.3 2.9 1.8
Total n 297 407 704
% 100.0 100.0 100.0
Dyslipidemia No n 217 294 511 0.905
% 72.8 72.4 72.6
Yes n 81 112 193
% 27.2 27.6 27.4
Total n 298 406 704
% 100.0 100.0 100.0
Obesity No n 269 376 645 0.320
% 90.3 92.4 91.5
Yes n 29 31 60
% 9.7 7.6 8.5
Total n 298 407 705
% 100.0 100.0 100.0
TIA No n 227 307 534 0.971
% 95.0 95.0 95.0
Yes n 12 16 28
% 5.0 5.0 5.0
Total n 239 323 562
% 100.0 100.0 100.0
AF No n 248 350 598 0.01
% 70.9 78.8 75.3
Yes n 102 94 196
% 29.1 21.2 24.7
Total n 350 444 794
% 100.0 100.0 100.0
Table 5
Thrombolytic treatment, functional outcome at discharge and in-hospital death by
geographical areas.
North Center South Total P value
Thrombolytic treatment No n 247 457 130 834 0.475
% 87.3 89.4 90.9 89.0
Yes n 36 54 13 103
% 12.7 10.6 9.1 11.0
Total n 283 511 143 937
% 100.0 100.0 100.0 100.0
mRS at discharge b=2 n 237 317 66 620 b0.001
% 56.8 66.7 46.2 59.9
3+ n 180 158 77 4155. Discussion
In this study, women were older than men at stroke onset with
the greatest discrepancies between 75–85 and≥86 years. These ﬁnd-
ings are consistent with those reported by other population studies
and registries [4,9]. Moreover, data from a EuropeanMulticenter Mul-
tinational Hospital-Based Registry examining a population of about
4,500 patients found that women were signiﬁcantly older compared
to men at stroke onset [7], as did the “Get with the Guidelines-
Stroke (GWTG-Stroke) Program,” where more stroke events were
reported to be in women >80 years [4], as well as data from a sys-
tematic review on sex differences in stroke epidemiology [18].
In this study population, women presented with more severe
strokes at onset than men measured by the NIHSS, but no speciﬁc
symptom proﬁles for any possible sex-related differences were eval-
uated. Currently, literature on differences in stroke severity between
the sexes is conﬂicting [19]. In fact, limited evidence suggests that
women with stroke present different symptoms than men, as it is
known for acute coronary syndrome [20]. Speciﬁcally, women are
reported to experience more aphasic disorders, visual ﬁeld distur-
bances and dysphagia than men; while there have been no reported
differences in either motor or sensory deﬁcits [21,22].
Furthermore, stroke in women is more frequently associated with
anterior circulation ischemia, while men are more likely to have cer-
ebellar and brainstem symptoms and higher incidences of posterior
circulation syndromes than women [23].
Two studies measuring the stroke severity with the Canadian Neu-
rological Scale reported different results. In one, women had greater
severity on presentation [19], whereas, the second study reported
no sex differences [9]. Two other studies measuring stroke severity
with NIHSS reported little or no sex differences [24,25], while a Dan-
ish study measuring stroke severity with the Scandinavian Stroke
Scale reported more severe stroke in women [26].
Other studies have reported impaired levels of consciousness in
women more frequently than men, which could contribute to greater
stroke severity [5,27].
In our cohort of patients, the severity of stroke at onset was great-
er in women regardless of age, that might be also related to their
higher pre-stroke morbidity. In this study, greater stroke severity in
women led to longer hospital stays. This ﬁnding has been conﬁrmed
by other studies. Elderly women tend to have longer hospital stays
also due to the fact that they more often live alone, are more socially
isolated and more severely ill at baseline [6].Table 3b
Multivariate logistic model for in-hospital death.
OR 95% CI
Age 1.05 (1.01–1.09)
NIHSS at onset 1.23 (1.17–1.29)
Lenght of stay 0.89 (0.84–0.94)
% 43.2 33.3 53.8 40.1
Total n 417 475 143 1035
% 100.0 100.0 100.0 100.0
In-hospital death No n 399 451 135 985 0.469
% 95.7 94.9 94.4 95.2
Yes n 18 24 8 50
% 4.3 5.1 5.6 4.8
Total n 417 475 143 1035
% 100.0 100.0 100.0 100.0
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comes compared to men. In this study, in fact, women were more dis-
abled, leading to a lower quality of life after stroke compared to men.
To date, only few studies have been conducted with the aim of
assessing sex-differences in functional outcome after stroke [6,8,28].
Data from these studies have shown that women have less favourable
outcomes, more physical impairments and limitations in activities of
daily living (ADL) measured by the Barthel Index compared to men
[8,9,23,29,30].
In this study, there was a higher prevalence of AF in women com-
pared to men, and this was probably due to their older age at the time
of stroke [31]. Several studies have shown that women are generally
at higher risk than men for cardioembolic stroke due to AF
[18,32,33], whereas others studies have failed to show this [34].
Given that AF is more prevalent in the elderly [35], and women
with AF are less treated than men with anticoagulant therapy in pri-
mary prevention [36], due to the facts they are less recruited in
RCTs [37], and have a higher risk of thromboembolic complications
from AF compared to men.
As cardioembolic stroke is more severe than other stroke subtypes
[38], the higher prevalence of AF is more than likely to explain the in-
creased stroke severity in women.
Women have been reported to have a higher stroke case-fatality
rate [18] while in our study population, this was not statistically sig-
niﬁcant. The high rates of loss to follow up at 90 days could explain
this result.
In our study, thrombolysis was administered with a slight preva-
lence in favour of men. This was probably highly inﬂuenced by the
fact that in Italy there is the age limit of 80 years for thrombolysis
treatment (EMEA). This means women ≥80 years of age, which is a
signiﬁcant stroke age group, are excluded a priori from thrombolysis
treatment. Recently published data from the IST 3-trial will induce
the decision to raise the EMEA thrombolysis age limit of 80 years [39].
Limitations of this study included the following: data were not ho-
mogeneous and came from different databases, there was a high per-
centage of loss to follow up and links between speciﬁc neurological
symptoms and severity were not evaluated for.
6. Conclusions
This study suggests, as in other studies, that sex-differences in
stroke patients do in fact exist, that women are older at stroke onset
with higher severity and have worse functional outcome compared
to men. Elderly women have been neglected for years by stroke re-
searchers. The only way to face this growing health emergency and
to limit health care costs is to better prevent cerebrovascular disease
in women. Based upon our observations, we believe that research on
sex differences in stroke should be encouraged to better address
acute stroke care also by sex.
Learning Points
• To understand potential sex-related differences in stroke manifes-
tations.
• To be aware of the different burden of cerebrovascular disease in
women and men.
• To emphasize the importance of including women in randomized
clinical trials.
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